NRZ — Neurizer Share Price
- AU$1.90m
- AU$3.44m
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 0.03 | ||
Price to Tang. Book | 0.03 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | n/a | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -3.49% | ||
Return on Equity | -7.69% | ||
Operating Margin | n/a |
Financial Summary
Year End 30th Jun | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | AU$m | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -100% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
NeuRizer Ltd is an Australia-based carbon neutral company. The Company is focused on the development of its NeuRizer Urea Project (NRUP). The NRUP project is located in South Australia, 550 kilometers north of Adelaide. The Company produces approximately one million tons per annum (Mtpa) of urea fertilizer with the potential to increase to two Mtpa.
Directors
- Daniel Peters CHM
- Phil Staveley CFO
- David Shearwood MDR
- Damien Connor SEC
- Murray Chatfield NED
- Zhe Wang NED
- Xiaojiang Zheng NED
- Last Annual
- June 30th, 2024
- Last Interim
- June 30th, 2024
- Incorporated
- January 28th, 2004
- Public Since
- March 17th, 2005
- No. of Shareholders
- 8,302
- No. of Employees
- 2
- Sector
- Chemicals
- Industry
- Basic Materials
- Exchange
Australian Stock Exchange - SEATS
- Shares in Issue
- 1,902,430,650

- Address
- Level 5, 19 Grenfell Street, ADELAIDE, 5000
- Web
- https://neurizer.com.au/
- Phone
- +61 881329100
- Auditors
- Ernst & Young
Upcoming Events for NRZ
Full Year 2025 NeuRizer Ltd Earnings Release
Similar to NRZ
Agrimin
Australian Stock Exchange - SEATS
Aguia Resources
Australian Stock Exchange - SEATS
Alexium International
Australian Stock Exchange - SEATS
Alpha HPA
Australian Stock Exchange - SEATS
Bio-Gene Technology
Australian Stock Exchange - SEATS
FAQ
As of Today at 22:14 UTC, shares in Neurizer are trading at AU$0.00. This share price information is delayed by 15 minutes.
Shares in Neurizer last closed at AU$0.00 and the price had moved by -66.67% over the past 365 days. In terms of relative price strength the Neurizer share price has underperformed the ASX All Ordinaries Index by -67.16% over the past year.
There is no consensus recommendation for this security.
Find out moreNeurizer does not currently pay a dividend.
Neurizer does not currently pay a dividend.
Neurizer does not currently pay a dividend.
To buy shares in Neurizer you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of AU$0.00, shares in Neurizer had a market capitalisation of AU$1.90m.
Here are the trading details for Neurizer:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: NRZ
Based on an overall assessment of its quality, value and momentum Neurizer is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Neurizer. Over the past six months, its share price has underperformed the ASX All Ordinaries Index by -73.58%.
As of the last closing price of AU$0.00, shares in Neurizer were trading -72.01% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Neurizer PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at AU$0.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Neurizer's management team is headed by:
- Daniel Peters - CHM
- Phil Staveley - CFO
- David Shearwood - MDR
- Damien Connor - SEC
- Murray Chatfield - NED
- Zhe Wang - NED
- Xiaojiang Zheng - NED